A PHASE IB, OPEN LABEL, MULTICENTER TRIAL OF PIXANTRONE, ETOPOSIDE, BENDAMUSTINE AND, IN CD20-POSITIVE TUMORS, RITUXIMAB (PREBEN) IN RELAPSED AGGRESSIVE LYMPHOMAS OF B- OR T-CELL PHENOTYPE
EHA Library, F D'Amore,
216625
A STUDY OF UPFRONT AUTOGRAFT FOLLOWING 3 TO 4 CYCLES OF BORTEZOMIB, LENALIDOMIDE AND DEXAMETHASONE BASED CHEMOTHERAPY IN 52 INDIAN MYELOMA PATIENTS – A TERTIARY CENTRE EXPERIENCE FROM CHENNAI,INDIA.
EHA Library, Kishore Kumar,
216670
AUTOLOGOUS STEM CELL TRANSPLANTATION OUTCOME IN NEWLY DIAGNOSED TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA IN SIRIRAJ HOSPITAL, BANGKOK, THAILAND : AN 18-YEAR FOLLOW-UP
EHA Library, Natthakan Tungsuksomboon,
216682
DONOR AND RECIPIENT CCR5-DELTA 32, CCR2-64I, SDF1-3'A , IL6 -572 C/G POLYMORPHISMS AND TRANSPLANTATION OUTCOME.
EHA Library, Natalya Risinskaya,
216689
IN MULTIPLE MYELOMA, AFTER CTX-BASED PBSC MOBILIZATION, THE USE OF HIGH DOSE G-CSF (10 MCG/KG) IS MORE EFFECTIVE IN RESPECT TO LOW DOSE G-CSF(5 MCG/KG) BUT ONLY IF PLERIXAFOR ON DEMAND IS NOT USED.
EHA Library, Giuseppe MILONE,
216702